Jinyu Bio-Technology Co

Jinyu Bio-Technology Co Rule of 40

The Rule of 40 of Jinyu Bio-Technology Co (600201.SS) as of Oct 31, 2026 is 19.80 %. In the previous year, Rule of 40 was -11.52 % — a change of -271.94% (higher).

Rule of 40

19.80 %

YoY

-271.94%

Last updated:

Rule of 40 of Jinyu Bio-Technology Co is 2025 19.80 % . Rule of 40 of Jinyu Bio-Technology Co was 2024 -11.52 % . It decreases by -271.94% higher compared to the previous year.

The Jinyu Bio-Technology Co Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
46.65 CNY
Jan 1, 2019
-18.08 CNY
Jan 1, 2020
70.59 CNY
Jan 1, 2021
35.63 CNY
Jan 1, 2022
2.75 CNY
Jan 1, 2023
24.27 CNY
Jan 1, 2024
-11.52 CNY
Jan 1, 2025
19.80 CNY
The Jinyu Bio-Technology Co Rule of 40 history
YEARRule of 40YoY
19.80 %-271.94%
-11.52 %-147.45%
24.27 %+783.94%
2.75 %-92.29%
35.63 %-49.52%
70.59 %-490.41%
-18.08 %-138.76%
46.65 %-41.14%
79.26 %+9.15%
72.61 %+12.33%
64.64 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jinyu Bio-Technology Co Stock analysis

What does Jinyu Bio-Technology Co do? Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas. Jinyu Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jinyu Bio-Technology Co stock

Rule of 40 of Jinyu Bio-Technology Co is 19.80 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Quality — Jinyu Bio-Technology Co

AAQSPiotroski F-ScoreAltman Z-ScoreGraham NumberRule of 40

All Key Metrics — Jinyu Bio-Technology Co